文献速递癫痫

钠通道基因Scn8a的长期下调对SCN8A癫痫小鼠模型具有治疗作用

Long-Term Downregulation of the Sodium Channel Gene Scn8a Is Therapeutic in Mouse Models of SCN8A Epilepsy.
PubMed 文献 · Ann Neurol · 2024-01-06

该研究在SCN8A发育性癫痫性脑病小鼠模型中,于惊厥发作后启动反义寡核苷酸(ASO)治疗并每4至6周重复给药持续1年,同时测试了新生期单次给予AAV10-shRNA病毒的长期疗效。结果显示重复ASO治疗和单次病毒shRNA均能减少发作并延长生存至12个月观察期。

要点

  • 发作后启动的重复ASO治疗可长期延长生存并减少发作频率。
  • 新生期单次AAV10-shRNA病毒治疗同样提供12个月保护。
  • 发作后下调Scn8a表达对SCN8A-DEE模型具有长期疗效。

核心结论

  • 在SCN8A-DEE小鼠模型中,发作后启动的Scn8a表达下调对长期治疗有效。
  • 重复ASO给药或单次病毒shRNA剂量可预防发作并延长生存至12个月观察期。

研究设计与样本

  • 在SCN8A癫痫小鼠模型中,于观察到惊厥发作后启动ASO治疗,每4至6周重复一次,持续1年。
  • 同时测试了新生期(P1)给予的AAV10-shRNA病毒的长期疗效。

主要发现

  • 发作后启动的重复Scn8a ASO治疗在12个月观察期内提供长期生存并减少发作频率。
  • 单次病毒shRNA治疗在12个月观察期内也具有保护作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: De novo mutations of the voltage-gated sodium channel gene SCN8A cause developmental and epileptic encephalopathy (DEE). Most pathogenic variants result in gain-of-function changes in activity of the sodium channel Nav1.6, poorly controlled seizures, and significant comorbidities. In previous work, an antisense oligonucleotide (ASO) reduced Scn8a transcripts and increased lifespan after neonatal administration to a mouse model. Here, we tested long-term ASO treatment initiated after seizure onset, as required for clinical application. METHODS: ASO treatment was initiated after observation of a convulsive seizure and repeated at 4 to 6 week intervals for 1 year. We also tested the long-term efficacy of an AAV10-short hairpin RNA (shRNA) virus administered on P1. RESULTS: Repeated treatment with the Scn8a ASO initiated after seizure onset provided long-term survival and reduced seizure frequency during a 12 month observation period. A single treatment with viral shRNA was also protective during 12 months of observation. INTERPRETATION: Downregulation of Scn8a expression that is initiated after the onset of seizures is effective for long-term treatment in a model of SCN8A-DEE. Repeated ASO administration or a single dose of viral shRNA prevented seizures and extended survival through 12 months of observation. ANN NEUROL 2024;95:754-759.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Hill SF, Yu W, Ziobro J, et al. Long-Term Downregulation of the Sodium Channel Gene Scn8a Is Therapeutic in Mouse Models of SCN8A Epilepsy. Ann Neurol. 2024. PMID: 38113311. doi:10.1002/ana.26861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。